• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视黄酸受体激动剂 Am80 增加老年 SAMP8 小鼠海马中的 ADAM10。

The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice.

机构信息

Department of Physiology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.

出版信息

Neuropharmacology. 2013 Sep;72:58-65. doi: 10.1016/j.neuropharm.2013.04.009. Epub 2013 Apr 23.

DOI:10.1016/j.neuropharm.2013.04.009
PMID:23624141
Abstract

The retinoic acid (RA, a vitamin A metabolite) receptor (RAR) is a transcription factor. Vitamin A/RA administration improves the Alzheimer's disease (AD)- and age-related attenuation of memory/learning in mouse models. Recently, a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) was identified as a key molecule in RA-mediated anti-AD mechanisms. We investigated the effect of chronic administration of the RAR agonist Am80 (tamibarotene) on ADAM10 expression in senescence-accelerated mice (SAMP8). Moreover, we estimated changes in the expression of the amyloid precursor protein (APP), amyloid beta (Aβ), and hairy/enhancer of split (Hes), which are mediated by ADAM10. Spatial working memory and the levels of a hippocampal proliferation marker (Ki67) were also assessed in these mice. ADAM10 mRNA and protein expression was significantly reduced in the hippocampus of 13-month-old SAMP8 mice; their expression improved significantly after Am80 administration. Further, after Am80 administration, the expression levels of Hes5 and Ki67 were restored and the deterioration of working memory was suppressed, whereas APP and Aβ levels remained unchanged. Our results suggest that Am80 administration effectively improves dementia by activating the hippocampal ADAM10-Notch-Hes5 proliferative pathway.

摘要

维甲酸(RA,维生素 A 的代谢物)受体(RAR)是一种转录因子。维生素 A/RA 给药可改善阿尔茨海默病(AD)和年龄相关的记忆/学习能力下降的小鼠模型。最近,一种解整合素和金属蛋白酶域蛋白 10(ADAM10)被鉴定为 RA 介导的抗 AD 机制中的关键分子。我们研究了 RAR 激动剂 Am80(他米巴罗汀)对加速老化小鼠(SAMP8)中 ADAM10 表达的慢性给药的影响。此外,我们还评估了由 ADAM10 介导的淀粉样前体蛋白(APP)、β-淀粉样蛋白(Aβ)和毛状/增强子分裂(Hes)的表达变化。在这些小鼠中还评估了空间工作记忆和海马增殖标志物(Ki67)的水平。13 月龄 SAMP8 小鼠海马中的 ADAM10 mRNA 和蛋白表达显著降低;Am80 给药后其表达显著改善。此外,Am80 给药后,Hes5 和 Ki67 的表达水平得到恢复,工作记忆的恶化得到抑制,而 APP 和 Aβ 水平保持不变。我们的研究结果表明,Am80 给药通过激活海马 ADAM10-Notch-Hes5 增殖途径有效改善痴呆。

相似文献

1
The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice.视黄酸受体激动剂 Am80 增加老年 SAMP8 小鼠海马中的 ADAM10。
Neuropharmacology. 2013 Sep;72:58-65. doi: 10.1016/j.neuropharm.2013.04.009. Epub 2013 Apr 23.
2
Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.维甲酸受体和类视黄醇X受体激动剂在阿尔茨海默病小鼠模型中的协同治疗作用。
J Alzheimers Dis. 2014;42(2):587-605. doi: 10.3233/JAD-132720.
3
Disturbance of rapid eye movement sleep in senescence-accelerated mouse prone/8 mice is improved by retinoic acid receptor agonist Am80 (Tamibarotene).衰老加速敏感 8 型小鼠快速眼动睡眠障碍可通过维甲酸受体激动剂 Am80(他米巴罗汀)得到改善。
Neuroscience. 2010 May 19;167(3):573-82. doi: 10.1016/j.neuroscience.2010.01.059. Epub 2010 Feb 4.
4
Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.维甲酸受体和阿维A对α-分泌酶ADAM10的上调作用。
FASEB J. 2009 Jun;23(6):1643-54. doi: 10.1096/fj.08-121392. Epub 2009 Jan 14.
5
Effects of ADAM10 deletion on Notch-1 signaling pathway and neuronal maintenance in adult mouse brain.ADAM10基因缺失对成年小鼠大脑中Notch-1信号通路及神经元维持的影响。
Gene. 2015 Jan 25;555(2):150-8. doi: 10.1016/j.gene.2014.10.056. Epub 2014 Nov 1.
6
Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.神经元特异性ADAM10调节在急性兴奋性毒性应激体内模型中的作用。
Neuroscience. 2008 Mar 18;152(2):459-68. doi: 10.1016/j.neuroscience.2007.10.060. Epub 2008 Jan 12.
7
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.ADAM10显性负性形式在阿尔茨海默病小鼠模型中的作用。
J Alzheimers Dis. 2009;16(2):309-14. doi: 10.3233/JAD-2009-0952.
8
Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.XBP-1 转录因子调控的未折叠蛋白反应信号通路调节 ADAM10 的表达,其在阿尔茨海默病中受到影响。
FASEB J. 2014 Feb;28(2):978-97. doi: 10.1096/fj.13-234864. Epub 2013 Oct 28.
9
Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β.维甲酸受体-α信号通路拮抗细胞内和细胞外淀粉样β的产生,并预防由淀粉样β引起的神经元细胞死亡。
Eur J Neurosci. 2010 Oct;32(8):1246-55. doi: 10.1111/j.1460-9568.2010.07426.x.
10
Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.苯丁酸降低 AD 转基因小鼠的淀粉样斑块,挽救认知行为。
Aging Cell. 2011 Jun;10(3):418-28. doi: 10.1111/j.1474-9726.2011.00680.x. Epub 2011 Mar 22.

引用本文的文献

1
Cancer drugs with high repositioning potential for Alzheimer's disease.具有高重新定位潜力的癌症药物可用于治疗阿尔茨海默病。
Expert Opin Emerg Drugs. 2023 Dec;28(4):311-332. doi: 10.1080/14728214.2023.2296079. Epub 2023 Dec 26.
2
Therapeutic insights elaborating the potential of retinoids in Alzheimer's disease.阐述维甲酸在阿尔茨海默病中潜在作用的治疗见解。
Front Pharmacol. 2022 Aug 23;13:976799. doi: 10.3389/fphar.2022.976799. eCollection 2022.
3
The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence.
抗氧化剂在氧化应激与衰老相互作用中的作用
Antioxidants (Basel). 2022 Jun 22;11(7):1224. doi: 10.3390/antiox11071224.
4
Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.视黄醇 X 受体 (RXRs) 和膳食维生素 A 在阿尔茨海默病中的作用:来自临床病理和临床前研究的证据。
Neurobiol Dis. 2021 Dec;161:105542. doi: 10.1016/j.nbd.2021.105542. Epub 2021 Nov 1.
5
Cornel Iridoid Glycoside Ameliorated Alzheimer's Disease-Like Pathologies and Necroptosis through RIPK1/MLKL Pathway in Young and Aged SAMP8 Mice.山茱萸环烯醚萜苷通过RIPK1/MLKL通路改善年轻和老年SAMP8小鼠的阿尔茨海默病样病理及坏死性凋亡
Evid Based Complement Alternat Med. 2021 Aug 23;2021:9920962. doi: 10.1155/2021/9920962. eCollection 2021.
6
Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.用于治疗阿尔茨海默病和帕金森病的靶标酶。
Biomed Res Int. 2020 Nov 9;2020:2010728. doi: 10.1155/2020/2010728. eCollection 2020.
7
Nuclear receptors in neural stem/progenitor cell homeostasis.神经干/祖细胞内稳态中的核受体
Cell Mol Life Sci. 2017 Nov;74(22):4097-4120. doi: 10.1007/s00018-017-2571-4. Epub 2017 Jun 21.
8
Regulation of Alpha-Secretase ADAM10 and : Genetic, Epigenetic, and Protein-Based Mechanisms.α-分泌酶ADAM10的调控:遗传、表观遗传和基于蛋白质的机制
Front Mol Neurosci. 2017 Mar 17;10:56. doi: 10.3389/fnmol.2017.00056. eCollection 2017.
9
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.核受体激动剂在阿尔茨海默病中的治疗潜力。
J Lipid Res. 2017 Oct;58(10):1937-1949. doi: 10.1194/jlr.R075556. Epub 2017 Mar 6.
10
Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Aβ1-42 Injection in Rats.边缘性维生素A缺乏加剧大鼠注射Aβ1-42后的记忆缺陷。
Curr Alzheimer Res. 2017;14(5):562-570. doi: 10.2174/1567205013666161223162110.